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of four classes of addictive drugs all increase AMPA/ their clear interaction with drug taking in animals and
NMDA ratios in VTA slices 24 hr after drug treatment in perhaps in humans as well (Shaham et al., 2000; Marinelli
vivo. Morphine, nicotine, ethanol, and either cocaine or and Piazza, 2002). Both the acquisition of drug taking
amphetamine, drugs with little in common beyond their and relapse in an already addicted animal are promoted
abuse potential, all have the same effect. Two other by either a single drug exposure or stress (Piazza and
psychoactive drugs with low abuse potential were Le Moal, 1998; Pacchioni et al., 2002). It is possible that
tested in similar experiments. Neither fluoxetine, the se- the work by Saal et al. (2003) identifies a neural substrate
rotonin transporter blocker and antidepressant better responsible for this common effect of abused drugs and
known as Prozac, nor carbamazepine, a widely pre- stress. Beyond the importance to our understanding of
scribed antiepileptic agent that slows recovery from in- the basic mechanisms underlying drug addiction, this
activation of voltage-dependent Na channels, has any study could point the way toward potential therapeutic
effect on AMPA/NMDA ratios at VTA synapses. Thus, approaches to relapse in human addicts.
the authors have revealed a single action of a diverse
group of compounds with distinct molecular targets but Julie A. Kauer
sharing the potential for producing addiction; drugs that Department of Molecular Pharmacology,
lack this potential, despite similar molecular targets, do Physiology, and Biotechnology
not alter VTA synapses. Brown University
The paper provides one last intriguing result: acute
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stress, here in the form of a brief forced swim in cold
water, potently increases the AMPA/NMDA ratio at VTA Selected Reading
synapses measured 24 hr later. Like the cocaine-induced
Everitt, B.J., and Wolf, M.E. (2002). J. Neurosci. 3312–3320.ratio increases reported previously, blockade of NMDA
receptors prior to the stressor entirely prevents the Hyman, S.E., and Malenka, R.C. (2001). Nat. Rev. Neurosci. 2,
695–703.change in AMPA/NMDA ratios. A glucocorticoid recep-
Jones, S., Kornblum, J.L., and Kauer, J.A. (2000). J. Neurosci. 20,tor antagonist, RU486, blocks stress-induced changes
5575–5580.as well, implicating glucocorticosteroids as an interme-
Malinow, R., and Malenka, R.C. (2002). Annu. Rev. Neurosci. 25,diary in the response to stress. In an interesting follow-
103–126.up to this experiment, the investigators tested whether
Marinelli, M., and Piazza, P.V. (2002). Eur. J. Neurosci. 16, 387–394.glucocorticoid receptor activation was required for co-
Nestler, E.J. (2001). Nat. Rev. Neurosci. 2, 119–128.caine-induced changes in the VTA. However, RU486
Pacchioni, A.M., Gioino, G., Assis, A., and Cancela, L.M. (2002). Ann.does not affect cocaine’s ability to elicit increased
N Y Acad. Sci. 965, 233–246.AMPA/NMDA ratios at VTA synapses. Thus, stress and
Piazza, P.V., and Le Moal, M. (1998). Trends Pharmacol. Sci. 19,drugs of abuse (at least cocaine) interact with the VTA
67–74.via distinct pathways, although both stress and cocaine
Robinson, T.E., and Berridge, K.C. (1993). Brain Res. Brain Res. Rev.require NMDA receptor activation to trigger this change.
18, 247–291.The work raises questions about the detailed mecha-
Saal, D., Dong, Y., Bonci, A., and Malenka, R.C. (2003). Neuron 37,nisms of drug action. How does activation of opiate
this issue, 577–582.receptors, dopamine transporters, GABAA channels, nic-
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Rev. 33, 13–33.
ceptors increase AMPA/NMDA ratios in the VTA? How
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all of these drugs, like cocaine and stress, require NMDA
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receptor activation to induce the ratio change? Are the
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Many larger questions are raised by this work. Clearly,
addiction to nicotine does not produce concomitant ad-
diction to cocaine or alcohol. Experiencing stress is not Filling the Interstices: Ghrelin
sufficient on its own to initiate addiction to drugs. And
Neurons Plug Several Holes ina single or even multiple exposures to alcohol, nicotine,
cocaine, or morphine are generally not enough to pro- Regulation of Energy Balance
duce addiction. How exactly does the brain interpret a
global potentiation of synapses in the VTA after any of
these stimuli? Perhaps the threshold for moving from
Of several circulating hormones that act on hypothala-drug exposure to addiction is reduced by recent expo-
mus to affect body energy balance, only ghrelin is alsosure to any addictive drug or to stress. The duration of
expressed in hypothalamic neurons. From the studiesthese effects seems extremely important. If all gluta-
of Horvath and colleagues appearing in this issue ofmatergic synapses on VTA dopamine neurons are po-
Neuron, it appears that neuronal ghrelin acts presyn-tentiated 24 hr after drug exposure or stress, for how
aptically to stimulate release of the orexigenic peptide,long does the potentiation last? Does the potentiation
neuropeptide Y, and other neurotransmitters, thus de-period represent a window of vulnerability to stress or
fining a new and subtle modulatory circuit.drug exposure?
Stress and glucocorticoids have been of particular
interest to researchers in the addiction field because of Food intake and energy expenditure are very closely
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guarded throughout life so that body weight and fat
stores remain remarkably constant. The hypothalamus
is the primary site in brain that regulates body weight
through adjustments in caloric intake and energy expen-
diture. In particular, neurons of the arcuate (ARC) nuclei
have dendrites that lie outside the blood-brain barrier.
These neurons are heavily endowed and decorated with
receptors for the appropriate hormones. These facts
enable ARC neurons to sample circulating hormone con-
centrations that reach the extracellular fluid.
Two hormones have long been proposed to control
feeding and energy expenditure. Insulin, the hormone
of plenty, is secreted after meals and acts, as proposed
by Woods and Porte, in brain to inhibit feeding and
increase energy expenditure through an action on re-
ceptors localized on neurons in the ARC. Selective
blockade of insulin receptors results in increased body
weight and adiposity (reviewed in Cummings and
Schwartz, 2003). Glucocorticoids also probably act
through their receptors in ARC neurons to increase feed-
ing, particularly when insulin concentrations are low
Schematic Model of Hormonal Regulation of Food Intake and Energy(Kellendonk et al., 2002; Strack et al., 1995).
StorageUnderstanding of the regulation of feeding and metab-
Two gut-related peptides, ghrelin and insulin, are secreted beforeolism took a giant stride when, in 1994, leptin, a hormone
and after feeding. Two other hormones reflect the state of energy
secreted primarily from fat cells, was identified and char- stores (glucocorticoids [GC] and leptin). Both ghrelin and GC con-
acterized and its receptors were found distributed centrations are elevated in negative energy balance, and both insulin
widely in brain, but particularly in the medial basal hypo- and leptin concentrations are increased in positive energy balance.
All four hormones act on orexigenic NPY/AGRP neurons in the arcu-thalamus. Leptin serves as a signal of plenty, like insulin,
ate n. of the hypothalamus to either stimulate (solid lines, arrow) orand it is secreted in proportion to fat mass. As with
inhibit (dashed lines, line) activity in NPY/AGRP cells and subse-insulin and glucocorticoids, leptin has receptors on ARC
quent feeding and energy balance. For clarity, only the effects on
neurons, where many of its effects are mediated (Cum- NPY cells are shown.
mings and Schwartz, 2003).
High circulating leptin concentrations produce lean-
ness and restore obese mice with genetic loss of leptin promote satiety (Casanueva and Dieguez, 2002; Cum-
(ob/ob) toward normal body mass. But a signal of low mings and Schwartz, 2003; Horvath et al., 2001).
body mass was missing, and the hypothesis that de- Thus, there is now a nice symmetry in hormones that
creases in circulating leptin resulted in hunger and re- regulate hypothalamic feeding and satiety behaviors.
duced energy expenditure in normal animals did not Two are secreted from structures in the gut before and
account for results of many studies. For instance, al- after food intake (ghrelin and insulin, respectively; see
though leptin concentrations fall rapidly when food is Figure). Both also increase tonically under conditions
removed just prior to the time of normal feeding in rats, of inanition and obesity, respectively (Casanueva and
other hormonal responses to the loss of food (decreased Dieguez, 2002). Then there are glucocorticoids (GC) and
insulin, increased ACTH, and corticosterone) precede leptin, which seem to signal the energy state of the
the drop in leptin (Dallman et al., 1999). What was body: glucocorticoids increase with inanition and leptin
needed was a clear hunger signal that also acts on ARC increases with obesity. All of these hormones have re-
and in other parts of brain to stimulate the production ceptors on ARC neurons, and thus can readily inform
of orexigenic peptides and inhibit the production of an- the hypothalamus about energy status (see Figure).
orexigenic peptides. However, of the four hormones, only ghrelin is made
In 1999, Kojima and colleagues isolated and charac- both in the periphery and in hypothalamic neurons.
terized a peptide, ghrelin, from stomach mucosal cells Orexigenic (Neuropeptide Y [NPY], Agouti-related pro-
(Kojima et al., 1999) that activates an orphan receptor, tein [AgRP]) and anorexigenic (POMC-derived -melano-
growth-hormone secretagogue receptor (GHS-R) pres- cyte stimulating hormone [MSH] and cocaine- and am-
ent throughout brain (Guan et al., 1997). GHS-R are heav- phetamine-regulated transcript [CART]) neuropeptides
ily expressed in the ARC, particularly associated with are synthesized in ARC neurons that contain insulin,
NPY-containing neurons. Very quickly, it was shown that leptin, ghrelin, and corticosteroid receptors. The an-
ghrelin increases in the circulation before each meal and orexigenic corticotropin-releasing factor (CRF) neurons
increases further in fasted or diabetic rats and people in the paraventricular nuclei (PVN) are directly innervated
with anorexia and bulemia nervosa. When injected into by fibers from both NPY/AGRP and MSH/CART cells
the periphery or icv, ghrelin increases feeding in both in ARC. ARC neurons respond appropriately in terms of
satiated and fasted rodents. Thus, ghrelin, like glucocor- the ensuing inhibition of feeding behavior to both insulin
ticoids, appears to serve as a true hormonal signal of and leptin signals, the activity of NPY cells decreases,
depleted body energy stores and promotes feeding, just and the activity of POMC cells increases. Insulin infused
intracerebroventricularly (icv) and leptin injected or in-as insulin and leptin signal plentiful energy stores and
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fused either parenterally or icv reduces food intake and four cell groups equally densely (see Table 1 in Cowley
increases energy expenditure. NPY/AgRP-expressing et al., 2003). Therefore, activity in the hypothalamic
neurons decrease activity, and POMC (MSH)/CART- group of ghrelin neurons may serve to coordinate func-
expressing neurons increase activity. Furthermore, NPY tion among these four cell groups.
potently stimulates feeding and reduction of energy ex- Another possibility is that the ghrelin neurons are posi-
penditure, whereas MSH inhibits feeding and stimu- tioned to integrate light-dark cycles with feeding. Inter-
lates energy expenditure (see Cowley et al., 2003 [this estingly, the extranuclear spaces in which ghrelin cell
issue of Neuron]; Cummings and Schwartz, 2003; Hor- bodies are now known to reside have previously been
vath et al., 2001). These works solved a major set of defined as a major area of endings from neurons in the
issues about the hypothalamic regulation of body suprachiasmatic nuclei (the subparaventricular zone;
weight. sPVZ), regulated by the endogenous circadian clock
However, ghrelin expression was also reported to oc- (Watts, 1991) and from the DMN and VMN (Elmquist et
cur in the hypothalamus (Kojima et al., 1999), unlike al., 1998). Lesions of the sPVZ alter the magnitude of
the other hormones discussed above. In this issue of luteinizing hormone secretion (Watts, 1991) and dampen
Neuron, Cowley and collaborators (Cowley et al., 2003) circadian rhythms in temperature and sleep-wake cy-
have elegantly described and closely examined the hy- cles (Lu et al., 2001). Moreover, when function in the VMN
pothalamic distribution of ghrelin neurons. Use of a new is blocked, diurnal rhythms in feeding, temperature, and
ghrelin knockout mouse showed no staining for ghrelin hormone secretion are strongly dampened, suggesting
in either hypothalamus or stomach, validating the multi- that this cell group interacts with the output of the circa-
ple antisera used to demonstrate the positive neurons. dian clock to amplify normal rhythms. When food intake
These cells lie not in one of the clearly visible medial is restricted to times of day that are remote from the
cell groups of the hypothalamus, including ARC and usual feeding time, the numbers of fos-expressing neu-
PVN, but rather tucked between these densely packed rons are increased in the sPVZ (Choi and Dallman, 1998)
cell groups in areas that appear quite unexciting in a in sites now known to contain ghrelin neurons. When
cresyl violet-stained section. However, efferent fibers the VMN are incapacitated and restricted feeding occurs
from the ghrelin neurons lie in the key hypothalamic out of phase with the normal sleep-activity cycle for
energy circuits including NPY/AGRP, POMC/CART, and the rat, temperature and hormone rhythms are strongly
CRF cells. Biotinylated ghrelin, at the light level, bound dampened and the sPVZ gains a rhythm in fos activation,
primarily to presynaptic NPY terminals. Using transgenic highest just before feeding (Choi and Dallman, 1998).
mice expressing fluorescent proteins in either POMC- This region of brain also receives afferent neural infor-
or NPY-synthesizing cells, the effects of ghrelin on elec- mation from the viscera, and ghrelin has been shown
trical activity in these cells was determined. Ghrelin stim- to inhibit activity in the afferent vagus (Date et al., 2002).
ulates activity in NPY neurons and decreases activity in Thus, another possible function of the hypothalamic
POMC neurons. The decreased activity in POMC cells ghrelin neurons is to serve as an interface between the
appears to be through the actions of NPY and GABA output of the circadian clock and cell groups that regu-
(some 30% of NPY neurons coexpress GABA). More- late energy balance.
over, ghrelin modulates the effects of NPY in the PVN, Whether either of these speculations about the role
an effect that was reduced by 50% by coinfusion of NPY of hypothalamic ghrelin proves to be correct, Horvath
receptor antagonists. Finally, a PVN cell shown to be and his collaborators (Cowley et al., 2003) have provided
inhibited by ghrelin was filled with biocytin and col- us with an elegant and subtle circuit that is novel and
abeled with CRF, showing the identity of the cell that may turn out to be a model for many other similar regula-
responded with a diminished inhibitory postsynaptic tory circuits in brain.
current to the peptide. The difficulty of this experiment
underlines the utility of having fluorescent protein ex-
Mary F. Dallmanpression for identification of specific peptide synthesiz-
Department of Physiologying cells. Building on their own results and on results
Program in Neurosciencesuggesting strongly that ghrelin acts through NPY/
School of MedicineAGRP, the authors propose a final model in which ghrelin
University of California, San Franciscoacts presynaptically to stimulate the release of orexi-
San Francisco, California 94143genic peptides and neurotransmitters and inhibit an-
orexogenic neurons. This relatively subtle modulation
Selected Readingrepresents a new brain circuit that is involved in energy
homeostasis. Casanueva, F.F., and Dieguez, C. (2002). Rev. Endocr. Metab. Dis-
The direct effects of ghrelin on NPY and POMC neu- ord. 2, 325–338.
rons in ARC probably reflect the effects that the circulat- Choi, S., and Dallman, M.F. (1998). J. Neurosci. 18, 3843–3852.
ing ghrelin signal would provide. Can we infer a role
Cowley, M.A., Smith, R.G., Diano, S., Tschop, M., Pronchuk, N.,
for the modulatory presynaptic ghrelin pathway? One Grove, K.L., Sotonyi, P., Strasburger, C.J., Bidlingmaier, M., Es-
possibility immediately comes to mind. Ghrelin neurons terman, M., et al. (2003). Neuron 37, this issue, 649–661.
abut all four medial basal hypothalamic cell groups that Cummings, D.E., and Schwartz, M.W. (2003). Annu. Rev. Med. 54,
clearly are involved with feeding and metabolism: the 453–471.
dorsomedial nuclei (DMN), the ventromedial nuclei Dallman, M.F., Akana, S.F., Bell, M.E., Bhatnagar, S., Choi, S., Chu,
(VMN), the ARC, and the PVN. Although the authors A., Horsley, C., Levin, N., Meijer, O.C., Strack, A.M., and Viau, V.
(1999). Endocrinology 140, 4015–4023.focused on ghrelin innervation and electrical actions in
ARC and PVN neurons, ghrelin processes innervate all Date, Y., Murakami, N., Toshinai, K., Matsukura, S., Niijima, A., Mat-
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